Fette Compacting introduced its next-generation platform of tableting equipment with the F10i for small batches.
courtesy of Fette Compacting
Fette Compacting introduced its next-generation platform of i-series tableting equipment with the F10i for small batches. The new i Series retains and improves upon the efficiency of the existing i Series. The F10i is a single rotary press for small batches, with optional containment for highly active substances. Producers can adapt the tablet press to different requirements using a handling arm to support turret changes and a mechanical, manual turret clamping system.
The new series supports production with highly potent ingredients. The press-room design has been optimized for cleaning, and approximately half of all enclosure parts have been removed, which reduces the surface of the enclosure parts to be cleaned by approximately 70%. The machine is also dust-tight to minimize cleaning efforts and the risk of cross-contamination.
The press has technical connectivity and can be integrated via plug-and-play and open interfaces for connections to the Internet of things and a manufacturing execution system. Server-based, real-time monitoring allows the user to monitor production processes using mobile devices. A radio-frequency identification (RFID) option uses a contactless transceiver system to automatically identify process components so that they can be compared against preset recipes. This RFID system increases process reliability and avoids tooling errors.
A human machine interface supports the user in the form of intuitive control, monitoring, and documentation of the machine and process equipment via a terminal. Tactile feedback, which generates a vibration and a sound when the operating keys are touched, provides added certainty when making entries. A workflow operation assistant in the software supports the user to implement workflows safely and without error.
Source: Fette
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.